I TUMORI SECONDARI DEL POLMONE: ANALISI DELLA LORO PROVENIENZA E STUDIO ANATOMO-CLINICO DELLA LORO CONFIGURAZIONE POLMONARE: INDAGINE CONDOTTA SU 1489 REFERTI AUTOPTICI NEL PERIODO GENNAIO 1974-MAGGIO 1978 = LES TUMEURS SECONDAIRES DU POUMON: ANALYSE DE LEUR ORIGINE ET ETUDE ANATOMOCLINIQUE DE LEUR CONFIGURATION PULMONAIRE. ETUDE CONDUITE SUR 1489 COMPTES RENDUS D'AUTOPSIE DE JANVIER 1974 A MAI 1978BELLI A; BELLI F.1978; G. ITAL. MAL. TORACE; ITA; DA. 1978; VOL. 32; NO 4; PP. 192-201; ABS. FRE/ENG/GER/SPA; BIBL. 37 REF.Article

A virtual view of a Maya City : La Milpa, Belize = Une image virtuelle d'une cité Maya : La Milpa, BelizeESTRADA BELLI, F.Context (Boston, Mass.). 1999, Vol 14, Num 2, pp 20-24, issn 1043-5247, 4 p.Article

An approach to the reliability optimization of software with redundancyBELLI, F; JEDRZEJOWICZ, P.IEEE transactions on software engineering. 1991, Vol 17, Num 3, pp 310-312, issn 0098-5589, 3 p.Article

LA SOPRAVVIVENZA DEL MALATO DI CANCRO DEL POLMONE IN RAPPORTO ALLE CONDIZIONI IMMUNOLOGICHE = LA SURVIE DU MALADE ATTEINT DU CANCER DU POUMON EN FONCTION DE L'ETAT IMMUNITAIREBELLI F; TIBERI R; DI MAURO D et al.1979; MINERVA PNEUMOL.; ITA; DA. 1979; VOL. 18; NO 1; PP. 23-30; ABS. ENG; BIBL. 22 REF.Article

Fault-tolerant programs and their reliabilityBELLI, F; JEDRZEJOWICZ, P.IEEE transactions on reliability. 1990, Vol 39, Num 2, pp 184-192, issn 0018-9529Article

STUDIO DI 40 CASI A LOCALIZZAZIONE PLEURO-POLMONARE IN CORSO DI "MORBO DI HODGKIN" = ETUDE DE 40 CAS A LOCALISATION PLEUROPULMONAIRE AU COURS DE LA "MALADIE DE HODGKIN"ROSSI P; BELLI F; BELLI A et al.1979; G. ITAL. MAL. TORACE; ITA; DA. 1979; VOL. 33; NO 1; PP. 42-51; ABS. FRE/ENG/GER/SPA; BIBL. 34 REF.Article

Specification of fault-tolerant system issues by predicate/transition nets and regular expressions-approach and case studyBELLI, F; GROSSPIETSCH, K.-E.IEEE transactions on software engineering. 1991, Vol 17, Num 6, pp 513-526, issn 0098-5589Article

Fault-tolerant programsBELLI, F; JEDRZEJOWICZ, P.Angewandte Informatik. 1988, Num 12, pp 533-538, issn 0013-5704Article

Polyketone polymer : A new support for direct enzyme immobilizationAGOSTINELLI, E; BELLI, F; TEMPERA, G et al.Journal of biotechnology. 2007, Vol 127, Num 4, pp 670-678, issn 0168-1656, 9 p.Article

What is the most promising strategy for the treatment of metastasizing melanoma? Viewpoint. CommentaryCASEINELLI, N; HEERLYN, M; STINGL, G et al.Experimental dermatology. 2000, Vol 9, Num 6, pp 439-451, issn 0906-6705Article

Results of EUS in detecting perirectal lymph node metastases of rectal cancer : the pathologist makes the differenceSPINELLI, P; SCHIAVO, M; MERONI, E et al.Gastrointestinal endoscopy. 1999, Vol 49, Num 6, pp 754-758, issn 0016-5107Article

Evaluation on serum 2'-5' oligoadenylate synthetase (2'-5' oligoAS) and β₂ microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-α2AMARTINETTI, A; SEREGNI, E; BELLI, F et al.Anticancer research. 1998, Vol 18, Num 3B, pp 2027-2030, issn 0250-7005Article

Hybrid strip-loaded waveguides on silicon substratesCASALBONI, M; BELLI, F; CIRILLO, M et al.Journal of sol-gel science and technology. 2003, Vol 26, Num 1-3, pp 937-941, issn 0928-0707, 5 p.Conference Paper

Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cellsARIENTI, F; BELLI, F; COLOMBO, M. P et al.Human gene therapy. 1999, Vol 10, Num 18, pp 2907-2916, issn 1043-0342Article

Manual dissection of adenocarcinoma of the lower third of the rectum specimens for detection of lymph node metastases smaller than 5 mmANDREOLA, S; LEO, E; BELLI, F et al.Cancer. 1996, Vol 77, Num 4, pp 607-612, issn 0008-543XArticle

Prevalence of sexual dysfunction in male cancer patients treated with rectal excision and coloanal anastomosisFILIBERTI, A; AUDISIO, R. A; GANGERI, L et al.European journal of surgical oncology. 1994, Vol 20, Num 1, pp 43-46, issn 0748-7983Conference Paper

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2ARIENTI, F; BELLI, F; PARMIANI, G et al.Cancer immunology and immunotherapy. 1993, Vol 36, Num 5, pp 315-322, issn 0340-7004Article

Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-β, rTNF-α, rIFN-γ, rIL4 and their combinationsMORTARINI, R; BELLI, F; PARMIANI, G et al.International journal of cancer. 1990, Vol 45, Num 2, pp 334-341, issn 0020-7136Article

Hyperthermic antiblastic perfusion in extracorporeal circulation: surgical technique and results in the treatment of extremities tumorVAGLINI, M; SANTINAMI, M; NAVA, M et al.The Journal of extra-corporeal technology. 1986, Vol 18, Num 1, pp 12-20, issn 0022-1058Article

First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancerVICI, P; AMODIO, A; DI LAURO, L et al.Oncology. 2000, Vol 58, Num 1, pp 3-7, issn 0030-2414Article

Neurotoxicity of interferon-α in melanoma therapy: Results from a randomized controlled trialCARACENI, A; GANGERI, L; MARTINI, C et al.Cancer. 1998, Vol 83, Num 3, pp 482-489, issn 0008-543XArticle

Autologous dendritic cells derived from CD34⁺ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of Melan-A/Mart-1_27-35-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursorsMORTARINI, R; ANICHINI, A; DI NICOLA, M et al.Cancer research (Baltimore). 1997, Vol 57, Num 24, pp 5534-5541, issn 0008-5472Article

Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor : limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patientsMAZZOCHI, A; BELLI, F; MASCHERONI, L et al.International journal of cancer. 1994, Vol 58, Num 3, pp 330-339, issn 0020-7136Article

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalanVAGLINI, M; BELLI, F; AMMATUNA, M et al.Cancer. 1994, Vol 73, Num 2, pp 483-492, issn 0008-543XArticle

Regional perfusion in the treatment of locally advanced pelvic cancerSANTINAMI, M; BELLI, F; VAGLINI, M et al.Regional cancer treatment. 1994, Vol 7, Num 1, pp 33-38, issn 0935-0411Article